{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:01:12Z","timestamp":1770962472708,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100024990","name":"National Yang Ming Chiao Tung University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100024990","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Pituitary Society established criteria to develop Pituitary Tumor Centers of Excellence (PTCOE) for optimization of patient care. These criteria were later transformed into quantitative standards based on real-life data from accredited pituitary centers worldwide. The aim of this study was to evaluate the pituitary tumor care capacity at our institute and compare it with the PTCOE criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We retrospectively reviewed the data of patients who underwent sellar, suprasellar, or parasellar surgery during 2021\u20132023 at Taipei Veterans General Hospital. Adults older than 18 years who were diagnosed with pituitary tumors were included. We collected data regarding baseline patient and tumor characteristics, the surgical method, complications, and activity volumes across involved departments. The relevant data were compared with those of the PTCOE standards.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 182 patients with pituitary tumors underwent surgery via the endoscopic endonasal approach during 2021\u20132023. Their median age was 51 (range, 20\u201391) years. Among them, 90.7% had macroadenomas. Functional remission rates were 55.6% for acromegaly, 69.2% for prolactinoma, and 93.3% for Cushing\u2019s disease. Our institute met the acceptable PTCOE criteria for the number of pituitary interventions, postoperative readmissions for complications, dynamic endocrine tests, neuroradiologists, and neuro-oncologists. Further, we met the preferred PTCOE criteria for mortality rate and the numbers of dedicated surgeons, endocrinologists, trained nurses, neuropathologists, and neuro-ophthalmologists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Most indicators in our study met the acceptable standards for a PTCOE. During the study period, the multidisciplinary team at our institute collaborated closely to provide comprehensive care for patients with pituitary adenomas.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11102-025-01563-8","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T16:54:10Z","timestamp":1755190450000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating pituitary tumor management: aligning with pituitary tumor centers of excellence criteria"],"prefix":"10.1007","volume":"28","author":[{"given":"Jin-Han","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Hsin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harn-Shen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"issue":"6","key":"1563_CR1","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","volume":"43","author":"S Melmed","year":"2022","unstructured":"Melmed S, Kaiser UB, Lopes MB, Bertherat J, Syro LV, Raverot G et al (2022) Clinical biology of the pituitary adenoma. Endocr Rev 43(6):1003\u20131037","journal-title":"Endocr Rev"},{"issue":"5","key":"1563_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11102-017-0838-2","volume":"20","author":"FF Casanueva","year":"2017","unstructured":"Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS et al (2017) Criteria for the definition of pituitary tumor centers of excellence (PTCOE): a pituitary society statement. Pituitary 20(5):489\u2013498","journal-title":"Pituitary"},{"issue":"5","key":"1563_CR3","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s11102-023-01345-0","volume":"26","author":"A Giustina","year":"2023","unstructured":"Giustina A, Uygur MM, Frara S, Barkan A, Biermasz NR, Chanson P et al (2023) Pilot study to define criteria for pituitary tumors centers of excellence (PTCOE): results of an audit of leading international centers. Pituitary 26(5):583\u2013596","journal-title":"Pituitary"},{"issue":"1","key":"1563_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11102-023-01360-1","volume":"27","author":"A Giustina","year":"2024","unstructured":"Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C et al (2024) Consensus on criteria for acromegaly diagnosis and remission. Pituitary 27(1):7\u201322","journal-title":"Pituitary"},{"issue":"12","key":"1563_CR5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR et al (2021) Consensus on diagnosis and management of cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9(12):847\u2013875","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"1563_CR6","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","volume":"19","author":"S Petersenn","year":"2023","unstructured":"Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BMK et al (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: a pituitary society international consensus statement. Nat Rev Endocrinol 19(12):722\u2013740","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"1563_CR7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s11102-019-00960-0","volume":"22","author":"D Esposito","year":"2019","unstructured":"Esposito D, Olsson DS, Ragnarsson O, Buchfelder M, Skoglund T, Johannsson G (2019) Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management. Pituitary 22(4):422\u2013434","journal-title":"Pituitary"},{"issue":"2","key":"1563_CR8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s12020-023-03400-z","volume":"81","author":"M Mavromati","year":"2023","unstructured":"Mavromati M, Mavrakanas T, Jornayvaz FR, Schaller K, Fitsiori A, Vargas MI et al (2023) The impact of transsphenoidal surgery on pituitary function in patients with non-functioning macroadenomas. Endocrine 81(2):340\u2013348","journal-title":"Endocrine"},{"issue":"3","key":"1563_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1055\/s-0039-1700498","volume":"82","author":"JW Grayson","year":"2021","unstructured":"Grayson JW, Nayak A, Winder M, Jonker B, Alvarado R, Barham H et al (2021) Multidisciplinary team care in the surgical management of pituitary adenoma. J Neurol Surg B Skull Base 82(3):295\u2013302","journal-title":"J Neurol Surg B Skull Base"},{"issue":"6","key":"1563_CR10","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1055\/a-1920-0758","volume":"83","author":"MK Ghiam","year":"2022","unstructured":"Ghiam MK, Ali IA, Dable CL, Ayala AR, Kargi AY, Komotar RJ et al (2022) Multidisciplinary postoperative care pathway to reduce readmissions following endoscopic transsphenoidal pituitary surgery: improving quality of patient care. J Neurol Surg B Skull Base 83(6):626\u2013634","journal-title":"J Neurol Surg B Skull Base"},{"issue":"1","key":"1563_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4158\/EP15894.OR","volume":"22","author":"AS Carminucci","year":"2016","unstructured":"Carminucci AS, Ausiello JC, Page-Wilson G, Lee M, Good L, Bruce JN et al (2016) Outcome of implementation of a multidisciplinary team approach to the care of patients after transsphenoidal surgery. Endocr Pract 22(1):36\u201344","journal-title":"Endocr Pract"},{"issue":"12","key":"1563_CR12","doi-asserted-by":"publisher","first-page":"4438","DOI":"10.1210\/jc.2014-2670","volume":"99","author":"M Mercado","year":"2014","unstructured":"Mercado M, Gonzalez B, Vargas G, Ramirez C, de los Monteros AL, Sosa E et al (2014) Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic. J Clin Endocrinol Metab 99(12):4438\u20134446","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1563_CR13","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.3171\/2019.6.JNS191187","volume":"133","author":"MJ Asha","year":"2020","unstructured":"Asha MJ, Takami H, Velasquez C, Oswari S, Almeida JP, Zadeh G et al (2020) Long-term outcomes of transsphenoidal surgery for management of growth hormone-secreting adenomas: single-center results. J Neurosurg 133(5):1360\u20131370","journal-title":"J Neurosurg"},{"key":"1563_CR14","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.wneu.2017.04.141","volume":"104","author":"JH Kim","year":"2017","unstructured":"Kim JH, Hur KY, Lee JH, Lee JH, Se YB, Kim HI et al (2017) Outcome of endoscopic transsphenoidal surgery for acromegaly. World Neurosurg 104:272\u2013278","journal-title":"World Neurosurg"},{"issue":"11","key":"1563_CR15","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1007\/s00701-017-3318-6","volume":"159","author":"CJ Chen","year":"2017","unstructured":"Chen CJ, Ironside N, Pomeraniec IJ, Chivukula S, Buell TJ, Ding D et al (2017) Microsurgical versus endoscopic transsphenoidal resection for acromegaly: a systematic review of outcomes and complications. Acta Neurochir (Wien) 159(11):2193\u20132207","journal-title":"Acta Neurochir (Wien)"},{"issue":"1","key":"1563_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11102-024-01485-x","volume":"28","author":"A Giustina","year":"2025","unstructured":"Giustina A, Uygur MM, Frara S, Barkan A, Biermasz NR, Chanson P et al (2025) Medical management pathways for Cushing\u2019s disease in pituitary tumors centers of excellence (PTCOEs). Pituitary 28(1):23","journal-title":"Pituitary"},{"issue":"4","key":"1563_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11102-024-01397-w","volume":"27","author":"A Giustina","year":"2024","unstructured":"Giustina A, Uygur MM, Frara S, Barkan A, Biermasz NR, Chanson P et al (2024) Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE). Pituitary 27(4):381\u2013388","journal-title":"Pituitary"},{"issue":"5","key":"1563_CR18","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jamcollsurg.2017.02.015","volume":"224","author":"DJ Cote","year":"2017","unstructured":"Cote DJ, Dasenbrock HH, Muskens IS, Broekman MLD, Zaidi HA, Dunn IF et al (2017) Readmission and other adverse events after transsphenoidal surgery: prevalence, timing, and predictive factors. J Am Coll Surg 224(5):971\u2013979","journal-title":"J Am Coll Surg"},{"issue":"3","key":"1563_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/2042018816687240","volume":"8","author":"A Prete","year":"2017","unstructured":"Prete A, Corsello SM, Salvatori R (2017) Current best practice in the management of patients after pituitary surgery. Ther Adv Endocrinol Metab 8(3):33\u201348","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"1","key":"1563_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11102-011-0347-7","volume":"15","author":"F Roelfsema","year":"2012","unstructured":"Roelfsema F, Biermasz NR, Pereira AM (2012) Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary 15(1):71\u201383","journal-title":"Pituitary"},{"key":"1563_CR21","doi-asserted-by":"publisher","first-page":"e447","DOI":"10.1016\/j.wneu.2018.03.006","volume":"114","author":"K Elshazly","year":"2018","unstructured":"Elshazly K, Kshettry VR, Farrell CJ, Nyquist G, Rosen M, Evans JJ (2018) Clinical outcomes after endoscopic endonasal resection of giant pituitary adenomas. World Neurosurg 114:e447\u2013e56","journal-title":"World Neurosurg"},{"key":"1563_CR22","doi-asserted-by":"crossref","unstructured":"Molteni G, Caiazza N, Fulco G, Sacchetto A, Gulino A, Marchioni D (2023) Functioning endocrine outcome after endoscopic endonasal Transsellar approach for pituitary neuroendocrine tumors. J Clin Med. 12(8)","DOI":"10.3390\/jcm12082986"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-025-01563-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-025-01563-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-025-01563-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T19:00:04Z","timestamp":1762282804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-025-01563-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1563"],"URL":"https:\/\/doi.org\/10.1007\/s11102-025-01563-8","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"21 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the institutional review board, Taipei Veterans General Hospital, under approval code 2025-02-001AC, in compliance with the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"91"}}